Clinical trial
Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients Continuous Renal Replacement Therapy Patients
NCT02355873 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients Continuous Renal Replacement Therapy Patients
- Lead sponsor
- Peking University First Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- August 31, 2015
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
critical ill patients, patients needing continuous renal replacement therapy